Этиологические и патогенетические факторы первичной артериальной гипертонии
Аннотация
В последние десятилетия накопилось достаточно данных, свидетельствующих, что артериальная гипертония (АГ) является полигенно наследуемой патологией. При этом недостаточная экскреция почками поваренной соли (ПС), генетически обусловленная или приобретенная (болезни, старение, ожирение и др.), является центральным механизмом патогенеза АГ. Развитие АГ необходимо рассматривать как компенсаторную реакцию, направленную на увеличение экскреции почками ПС и нормализацию объема гомеостаза и циркулирующей крови.
Об авторах
В. С. ВолковРоссия
зав.кафедрой госпитальной терапии
А. П. Тофило
Россия
доцент кафедры усовершенствования врачей
Список литературы
1. Ланг Г.Ф. Гипертоническая болезнь. Л. Медгиз 1950; 496 с.
2. Fujita T, Katsuyuki A. Salt, Blood Pressure and Kidney. In Kidney and Blood Pressure Regulation. Contrib Nephrol Basel Karger 2004; 143:172.
3. Guyton AC. Kidneys and fluids in pressure regulation. Small volume but large pressure changes 1992; Hypertension: 19(Suppl. 1): 12-8.
4. Guyton AC, Coleman TG, Cowley AW, et al. Arterial pressure regulation: overriding dominance of the kidneys in long-term regulation and in hypertension. Am J of Medicine 1972; 52: 584-94.
5. Kumar & Clark. Clinical Medicine. 6 Edition. Elsevier Inc. 2006. 1365 p.
6. Oxford Textbook of Medicine 4th edition (March 2003): by David A. Warrell (Editor), Timothy M. Cox (Editor), John D. Firth (Editor), Edward J., J R., M.D. Benz. (Editor) By Oxford Press: 3623 р
7. Guyton AC, Hall JE, Lohmeier ThE, et a1. Blood pressure regulation: basis concepts. Fed Proc 1981; 40: 2252-6.
8. Staessen JA, Wang J, Bianchi G, et al. Essential hypertension. Lancet 2003; 361: 1629- 34.
9. Luft FC. Geneticism of essential hypertension. Hypertension 2004; 43: 1155- 61.
10. Benjafield AV, Wang WY, Speirs HJ, et al. Genome-wide scan for hypertension in Sydney Sibships: The GENIHUSS study. Am J Hypertens 2005; 18: 828- 33.
11. Caulfield M, Munroe P, Pembroke J, et al. Genome-wide mapping of human loci for essential hypertension. Lancet 2003; 361: 2118-25.
12. de Lange M, Spector TD, Andrew T. Genome-wide scan for blood pressure suggests linkage to chromosome 11, and replication of loci on 16, 17, and 22. Hypertension 2004; 44: 872-7.
13. Schwartz F, Duka A, Sun F, et al. Mitochondrial genome mutations in hypertensive individuals. Am J Hypertens 2004; 17: 629-35.
14. Bianchi G, Fox U, Di Francesco GF, et al. Blood pressure changes producedby kidney cross-transplantation between spontaneously hypertensive and normotensive rats. Clin Sci Mol Med 1974; 47: 435-48.
15. Rettig R, Folberth C, Strauss H, et al. Hypertension transmitted by kidneys from stroke-prone spontaneously hypertensive rats. Am J Physiol 1989; 257: 197-203.
16. Manunta P, Cerutti R, Bernardi L, et al. Renal genetic mechanisms of essential hypertension. J Nephrol 1997; 10: 172-8.
17. Mein CA, Caulfield MJ, Dobson RJ, et al. Genetics of essential hypertension. Hum Mol Genet 2004; 13 Spec No 1:169-73.
18. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-11.
19. Marcantoni C, Ma L-J, Federspiel C, Fogo AB. Hypertensive nephrosclerosis in African-Americans vs Caucasians. Kidney Int 2002; 62: 172-80.
20. Fields LE, Burt VL, Cutler JA, et al. The burden of adult hypertension in the United States 1999-2000: A rising tide. Hypertension 2004; 44: 398-403 .
21. Parmer RJ, Stone RA, Cervenka JH. Renal hemodynamics in essential hypertension: Racial differences in response to changes in dietary sodium. Hypertension 1994; 24: 752-7.
22. Rostand SG. Hypertension and renal disease in blacks: Role of genetic and/or environmental factors? Adv Nephrol Necker Hosp 1992; 21: 99-105.
23. Suthanthiran M, Li B, Song JO, et al. Transforming growth factor-beta 1 hyperexpression in African American hypertensives: A novel mediator of hypertension and/or target organ damage. Proc Natl Acad Sci USA 2000; 97: 3479-84.
24. Manalich R, Reyes L, Herrera M, et al. Relationship between weight at birth and the number and size of renal glomeruli in humans: A histomorphometric study. Kidney Int 2000; 58: 770-6.
25. Pharoah POD, Stevenson CJ, West CR. Association of blood pressure in adolescence with birth weight. Arch Dis Child Fetal Neonatal 1998; 79: 114-20.
26. Toto RD. Hypertensive nephrosclerosis in African Americans. Kidney Int 2003; 64: 2331-6.
27. Keller G, Zimmer G, Mall G, et al: Nephron number in patients with primary hypertension. N Engl J Med 2003; 348: 101-8.
28. Harrison’s Prinsiples of Internal Medisine 2008;17-th Edition: 3352 р.
29. Bright, R. Tabular view of the morbid appearances in 100 cases connected with albuminous urine. Guy’s Hospital Reports 1836; 1: 380-400.
30. Cowley AW Jr. Long-term control of arterial blood pressure. Physiol Rev 1992; 72: 231-300.
31. Вандер А. Физиология почек. Пер. с англ. и ред. акад. Ю.В.Наточина. СПБ “Питер” 2000; 252 c.
32. Fujita T, Henry WL, Bartter FC, et al. Factors influencing blood pressure in human subjects with idiopathic hypertension. Am J Med 1980; 69: 334-44.
33. Kawasaki T, Delea CS, Bartter FC, Smith H. The effect of high-sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension. Am J Med 1978; 64: 193-8.
34. Contrib Nephrol 2004; Basel: Karger:vol 143:172 p.
35. Laragh JH: Laragh’s lesson in renin system pathophysiology for treating hypertension and its fatal cardiovascular consequences 2002; New York: Elsevier Science: 76 р.
36. Hall JE. The kidney, hypertension, and obesity. Hypertension 2003; 41: 625-33.
37. Hall JE, Mizelle HL, Brands MW, Hildebrand DA. Pressure natriuresis and angiotensin II in reduced kidney mass, salt-induced hypertension. Am J of Physiology 1992; 262: 61-71.
38. Oxford Textbook of Clinical Nephrology, 3rd Edition. Editors: Davison, Alex M.; Cameron, J. Stewart; Grunfeld, Jean-Pierre; Ponticelli, Claudio; Ritz, Eberhard; Winearls, Christopher G.; Ypersele, Charles van Title: Copyright 2005. Oxford University Press. 2643 p.
39. Johnson RJ, Herrera-Acosta J, Schreiner GF, Rodriguez-Iturbe B. Subtle acquired renal injury as a mechanism of salt sensitive hypertension. New Engl J Med 2002; 346: 918-23.
40. Ruilope LM, van Veldhuisen DJ, Ritz E, Luscher TF. Renal function: the Cinderella of cardiovascular risk. JACC 2001; 38: 1782-7.
41. Morimoto A, Uzu T, Fujii T, et al. Sodiumsensitivity and cardiovascular events in patients with essential hypertension. Lancet 1997; 350: 1734-7.
42. Ono A, Kuwaki T, Kumada M, Fujta T. Differential central modulation of the baroreflex by saltloading in normotensive and spontaneously hypertensive rats. Hypertension 1997; 29: 808-14.
43. Fujita T, Sato Y. Hypotensive effect of taurine: Possible involvement of the sympathetic nervoussystem and endogenous opiates. J Clin Invest 1988; 82: 993-7.
44. Fujita T, Sato Y. Role of hypothalamic-renal noradrenergic systems in hypotensive action of potassium. Hypertension 1992; 20: 466-72.
45. Sato Y, Ando K, Ogata E, Fujita T. High potassium intake attenuates antinatriuretic response to airstress in DOCA-salt rats. Am J Physiol 1991; 260: 941-5.
46. Esler MD, Hasking GJ, Willett IR, et al. Noradrenaline release and sympathetic nervous system activity. J Hypertens 1985; 3: 117-29.
47. Hollenberg NK, Williams GH, Adams DF: Essential hypertension: Abnormal renal vascular and endocrine response to a mild psychological stimulus. Hypertension 1981; 3: 11-7.
48. Fujita T, Sato Y. Natriuretic and antihypertensive effects of potassium in DOCA-salt hypertensive rats. Kidney Int 1983; 24: 731-9.
49. Fujta T, Ando K. Hemodynamic and endocrine changes associated with potassium supplementationin sodium-loaded hypertensives. Hypertension 1984; 6: 184-92.
50. Гинзбург М.М., Козлупица Г.С. Значение распределения жира при ожирении. Пробл эндокрин 1996; 42(3):42-6.
51. Buckland Y. The obesity epidemic. J Fam Health Care 2002; 12(4): 111-7.
52. Labib M. The investigation and management of obesity. J Clin Path 2003; 56: 17-25.
53. Федорова Е.Ю., И.М.Кутырина. Механизмы прогрессирования поражения почек при ожирении (Обзор литературы). Нефрология и диализ 2006; 8:2: 102-11.
54. Suzuki M, Kimura Y, Tsushima M, Harano Y. Association of insulin resistance with salt sensitivity and nocturnal fall of blood pressure. Hypertension 2000; 35: 864-8.
55. Ferrannini E, Barrett E, Bevilacqua S, et al. Sodium elevates the plasma glucoseresponse to glucose ingestion in man. J Clin Endocrinol Metab 1982; 54: 455-8.
56. Len da DM, Boegehold MA. Effect of a high-salt diet on oxidant enzyme activity in skeletal musclemicrocirculation. Am J Physiol 2002; 282: 395-402.
57. Meng S, Roberts J II, Cason GW, et al. Superoxide dismutase and oxidativestress in Dahl salt-sensitive and -resistant rats. Am J Physiol 2002; 283: 732-8.
58. Rugale C, Delbose S, Cristol JP, et al. Sodium restriction prevents cardiac hypertrophyand oxidative stress in angiotensin II hypertension. Am J Physiol 2003; 284: 1744-50.
59. Ishimitsu T, Tobian L, Sugimoto K, Everson T. High potassium diets reduce vascular and plasma lipid peroxidases in stroke-prone spontaneously hypertensive rats. Clin Exp Hypertens 1996; 18: 659-73.
60. Tobian L, Lange J, Ulm K, et al. Potassium reduces cerebral hemorrhage and death rate in hypertensive rats, even when blood pressure is not lowered. Hypertension 1985;7(Suppl I): 110-4.
61. Brenner BM, Mackenzie HS. Nephron mass as a risk factor for progression of renal disease. Kidney Int Suppl 1997; 63: 124-7.
62. Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesisof progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease.N Engl J Med 1982; 307: 652-9.
63. Hostetter TH, Olson JL, Rennke HG, et al. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 1981; 241: 85-93.
64. Dworkin LD, Feiner HD. Glomerular injury in uninephrectomized spontaneously hypertensiverats. A consequence of glomerular capillary hypertension. J Clin Invest 1986; 77: 797-809.
65. Johnson RJ, Alpers CE, Yoshimura A, et al. Renal injury from angiotensin II-mediated hypertension. Hypertension 1992; 19: 464-74.
66. Bohle A, Kressel G, Muller CA, et al. The pathogenesis of chronic renal failure. Pathol ResPract 1989; 185: 421-40.
67. Bohle A, Mackensen-Haen S, von Gise H, et al. The consequences of tubulo-interstitialchanges for renal function in glomerulopathies. A morphometric and cytological analysis. Pathol Res Pract 1990; 186: 135-44.
68. Risdon RA, Sloper JAC, de Wardener HE. The relationship between renal function andhistological changes found in renal biopsy specimens from patients with persistent glomerulоnephritis. Lancet 1968; 2: 363-6.
69. Struiker GE, Schainuck LI, Cutler RE, et al. Structural-functional correlations in renal disease.I. A method for assaying and classifying histopathologic changes in renal disease. Hum Pathol 1970; 1: 631-41.
70. Hayashi K, Epstein M, Loutzzenhiswer R, et al. Impaired myogenic responsiveness of theafferent arteriole in streptozocin-induced diabetic rats: role of eicosanoid derangements. J Am Soc Nephrol 1992; 2: 1578-86.
71. Pelayo JC, Westcott JY. Impaired autoregulation of glomerular capillary hydrostatic pressurein the rat remnant nephron. J Clin Invest 1991; 88: 101-5.
72. Barretti P, Soares V. Importance of early and continuous use of protein restriction on the progression of adriamycin nephropathy. Ren Fail 1999; 21: 603-13.
73. Bertani T, Zoja C, Abbate M, et al. Age-related nephropathy and proteinuria in rats with intact kidneys exposed to diets with different protein content. Lab Invest 1989; 60: 196-204.
74. Brenner BM. Nephron adaptation to renal injury or ablation. Am J Physiol 1985; 249: 324-37.
75. Neugarten J, Feiner HD, Schacht RG, Baldwin DS. Amelioration of experimental glomerulonephritisby dietary protein restriction. Kidney Int 1983; 24: 595-601.
76. Zatz R, Meyer TW, Rennke HG, et al. Predominance of hemodynamic rather than metabolicfactors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci USA 1985; 82: 5963-7.
77. Stamler J, Elliott MB, Kesteloot H, et al. Inverse relation of dietary protein markers with blood pressure: findings for 10020 men and women in the Intersalt Study. Circulation 1996; 94: 1629-34.
78. Mitch WE. Beneficial responses to modified diets in treating patients with chronic kidney disease. Kidney Int 2005; 67(Suppl 93): 133-5.
79. Meyrier A, Simon P. Nephroangiosclerosis and hypertension: things are not as simple as you might think. Nephrol Dial Transplant 1996; 11: 2116-20.
80. Bohle A, Wehrmann M, Greschniok A, Junghans R. Renal morphology inessential hypertension: analysis of 1177 unselected cases. Kidney Int 1998; Suppl 67: 205-6.
81. Olson JL. Hypertension: essential and secondary forms. In: Heptinstall’sPathology of the Kidney, 5th ed. Jennette JC, Olson JL, Schwartz M, Silva FG,eds. Philadelphia: Lippincott-Raven 1998; 943-1001.
82. Kincaid-Smith P, Whitworth JA. Hypertension and the kidney. In: The Kidney:A Clinicopathologic Study. Eds: Kincaid-Smith P, Whitworth JA. Melbourne: Blackwell, 1987; 131.
83. Шулутко Б.И., Перов ЮЛ. Артериальная гипертензия. СПб.: «Лига» 1993; 304 с.
84. Miall WE, Oldham PD. Factors influencing arterial blood pressure in the general population. Clin Sci 1958; 17: 409-16.
85. Andreucci VE, Fuiano G, Russo D, et al. Vasomotor nephropathy in the eldery. Nephrol Dial Transplant 1998; Vol 13(Suppl.7): 17-24.
Рецензия
Для цитирования:
Волков В.С., Тофило А.П. Этиологические и патогенетические факторы первичной артериальной гипертонии. Кардиоваскулярная терапия и профилактика. 2010;9(7):105-111.
For citation:
Volkov V.S., Tofilo A.P. Aetiological and pathogenetic factors of primary arterial hypertension. Cardiovascular Therapy and Prevention. 2010;9(7):105-111. (In Russ.)